Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Ad-CEA vaccine |
Trade Name | |
Synonyms | |
Drug Descriptions |
Ad-CEA is a cancer vaccine expressing carcinoembryonic antigen (CEA), which may result in an improved anti-tumor immune response (PMID: 15906358, PMID: 17053815, PMID: 31192764). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ad-CEA vaccine | Ad-CEA vaccine | 0 | 0 |
Ad-CEA vaccine + Avelumab + Bevacizumab + Capecitabine | Ad-CEA vaccine Avelumab Bevacizumab Capecitabine | 0 | 1 |
Ad-CEA vaccine + Avelumab + Bevacizumab + Capecitabine + Fluorouracil + Leucovorin + Oxaliplatin | Ad-CEA vaccine Avelumab Bevacizumab Capecitabine Fluorouracil Leucovorin Oxaliplatin | 0 | 1 |